Medical Devices Industry Reports Respiratory Heaters Market | Page 2

REPORT DESCRIPTION
Respiratory Heaters Market – Overview
An increase in prevalence and incidence of respiratory diseases such as asthma and chronic obstructive pulmonary
disease (COPD) is a major factor that is expected to augment growth of respiratory heaters market. The Global
Burden of Disease Study gives the prevalence of 251 million cases of COPD in 2016 and the bronchial asthma has
approximately 358.2 million cases in 2015. The market is also driven by factors such as growing geriatric
population, high prevalence of smoking, increasing pollution level.
COPD is a progressive life threatening lung disease which is not curable but can be controlled by respiratory
heaters. COPD is an under-diagnosed, life threatening lung disease that may progressively lead to death.
On the other hand, high cost of devices and undefined reimbursement policies in rural areas are factors restraining
the market growth. For instance, on 12 December 2017, Teleflex Incorporated, a leading global provider of
medical technologies, announced that its respiratory division has signed a new group purchasing agreement with
Health Trust. The agreement covers Teleflex's full line of active humidification, non-invasive ventilation (NIV),
and high flow nasal cannula therapy (HFNCT) products.